Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_anomalous, AVS_full, LACS
BMRB Entry DOI: doi:10.13018/BMR5785
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Arumugam, S.; Van Doren, Steven. "Global Orientation of Bound MMP-3 and N-TIMP-1 in Solution via Residual
Dipolar Couplings " Biochemistry 42, 7950-7958 (2003).
PubMed: 12834347
Assembly members:
Matrix MetalloProteinases-3 or stromelysin 1, polymer, 173 residues, 19492 Da.
N-terminal domain of Tissue Inhibitor of MatrixmetalloProteinases-1, polymer, 126 residues, 14252 Da.
CA, non-polymer, 40.078 Da.
ZN, non-polymer, 65.409 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pGEMEX-MMP-3(DC)
Entity Sequences (FASTA):
Matrix MetalloProteinases-3 or stromelysin 1: FRTFPGIPKWRKTHLTYRIV
NYTPDLPKDAVDSAVEKALK
VWEEVTPLTFSRLYEGEADI
MISFAVREHGDFYPFDGPGN
VLAHAYAPGPGINGDAHFDD
DEQWTKDTTGTNLFLVAAHQ
IGHSLGLFHSANTEALMYPL
YHSLTDLTRFRLSQDDINGI
QSLYGPPPDSPET
N-terminal domain of Tissue Inhibitor of MatrixmetalloProteinases-1: CTCVPPHPQTAFCNSDLVIR
AKFVGTPEVNQTTLYQRYEI
KMTKMYKGFQALGDAADIRF
VYTPAMESVCGYFHRSHNRS
EEFLIAGKLQDGLLHITTCS
FVAPWNSLSLAQRRGFTKTY
TVGCEE
Data type | Count |
1H chemical shifts | 729 |
13C chemical shifts | 495 |
15N chemical shifts | 138 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | Matrix MetalloProteinase-3 catalytic domain | 1 |
2 | N-TIMP-1, inhibitor | 2 |
3 | CALCIUM (II) ION, I | 3 |
4 | CALCIUM (II) ION, II | 3 |
5 | CALCIUM (II) ION, III | 3 |
6 | ZINC (II) ION, I | 4 |
7 | ZINC (II) ION, II | 4 |
Entity 1, Matrix MetalloProteinase-3 catalytic domain 173 residues - 19492 Da.
1 | PHE | ARG | THR | PHE | PRO | GLY | ILE | PRO | LYS | TRP | ||||
2 | ARG | LYS | THR | HIS | LEU | THR | TYR | ARG | ILE | VAL | ||||
3 | ASN | TYR | THR | PRO | ASP | LEU | PRO | LYS | ASP | ALA | ||||
4 | VAL | ASP | SER | ALA | VAL | GLU | LYS | ALA | LEU | LYS | ||||
5 | VAL | TRP | GLU | GLU | VAL | THR | PRO | LEU | THR | PHE | ||||
6 | SER | ARG | LEU | TYR | GLU | GLY | GLU | ALA | ASP | ILE | ||||
7 | MET | ILE | SER | PHE | ALA | VAL | ARG | GLU | HIS | GLY | ||||
8 | ASP | PHE | TYR | PRO | PHE | ASP | GLY | PRO | GLY | ASN | ||||
9 | VAL | LEU | ALA | HIS | ALA | TYR | ALA | PRO | GLY | PRO | ||||
10 | GLY | ILE | ASN | GLY | ASP | ALA | HIS | PHE | ASP | ASP | ||||
11 | ASP | GLU | GLN | TRP | THR | LYS | ASP | THR | THR | GLY | ||||
12 | THR | ASN | LEU | PHE | LEU | VAL | ALA | ALA | HIS | GLN | ||||
13 | ILE | GLY | HIS | SER | LEU | GLY | LEU | PHE | HIS | SER | ||||
14 | ALA | ASN | THR | GLU | ALA | LEU | MET | TYR | PRO | LEU | ||||
15 | TYR | HIS | SER | LEU | THR | ASP | LEU | THR | ARG | PHE | ||||
16 | ARG | LEU | SER | GLN | ASP | ASP | ILE | ASN | GLY | ILE | ||||
17 | GLN | SER | LEU | TYR | GLY | PRO | PRO | PRO | ASP | SER | ||||
18 | PRO | GLU | THR |
Entity 2, N-TIMP-1, inhibitor 126 residues - 14252 Da.
1 | CYS | THR | CYS | VAL | PRO | PRO | HIS | PRO | GLN | THR | ||||
2 | ALA | PHE | CYS | ASN | SER | ASP | LEU | VAL | ILE | ARG | ||||
3 | ALA | LYS | PHE | VAL | GLY | THR | PRO | GLU | VAL | ASN | ||||
4 | GLN | THR | THR | LEU | TYR | GLN | ARG | TYR | GLU | ILE | ||||
5 | LYS | MET | THR | LYS | MET | TYR | LYS | GLY | PHE | GLN | ||||
6 | ALA | LEU | GLY | ASP | ALA | ALA | ASP | ILE | ARG | PHE | ||||
7 | VAL | TYR | THR | PRO | ALA | MET | GLU | SER | VAL | CYS | ||||
8 | GLY | TYR | PHE | HIS | ARG | SER | HIS | ASN | ARG | SER | ||||
9 | GLU | GLU | PHE | LEU | ILE | ALA | GLY | LYS | LEU | GLN | ||||
10 | ASP | GLY | LEU | LEU | HIS | ILE | THR | THR | CYS | SER | ||||
11 | PHE | VAL | ALA | PRO | TRP | ASN | SER | LEU | SER | LEU | ||||
12 | ALA | GLN | ARG | ARG | GLY | PHE | THR | LYS | THR | TYR | ||||
13 | THR | VAL | GLY | CYS | GLU | GLU |
Entity 3, CALCIUM (II) ION, I - Ca - 40.078 Da.
1 | CA |
Entity 4, ZINC (II) ION, I - Zn - 65.409 Da.
1 | ZN |
sample_1: Matrix MetalloProteinases-3 or stromelysin 1, [U-98% 15N], 0.8 mM; N-terminal domain of Tissue Inhibitor of MatrixmetalloProteinases-1 0.8 mM
sample_2: Matrix MetalloProteinases-3 or stromelysin 1, [U-98% 13C; U-98% 15N], 0.8 mM; N-terminal domain of Tissue Inhibitor of MatrixmetalloProteinases-1 0.8 mM
sample_3: Matrix MetalloProteinases-3 or stromelysin 1, [U-96% 2H], 0.6 mM; N-terminal domain of Tissue Inhibitor of MatrixmetalloProteinases-1 0.6 mM
EXP-COND_1: pH: 6.6; temperature: 310 K; ionic strength: 0.145 M
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
not available | not available | not available | EXP-COND_1 |
SYBYL TRIAD v6.2, 6.3, 6.6 - data process, data analysis
BMRB | 4327 5154 5153 5154 4327 5099 |
PDB | |
DBJ | BAA01913 BAG34878 BAG52016 BAG52016 BAA01913 BAG34878 |
EMBL | CAA26443 CAA26902 CAG28566 CAG46779 CAH90650 CAG46779 CAH90650 CAA26902 CAG28566 CAA26443 |
GB | AAA52436 AAA63234 AAA99943 AAD14009 AAH00866 |
PIR | JC4303 JC4303 |
PRF | 1107278A 1308125A 1107278A 1308125A |
REF | NP_001028111 NP_001125351 NP_003245 XP_003271098 XP_003917687 NP_001028111 NP_003245 |
SP | P01033 P49061 Q5RC60 Q95KL9 |
SWISS-PROT | Q5RC60 Q95KL9 P01033 P49061 |
GenBank | AAH00866 AAA99943 AAD14009 AAA52436 AAA63234 |
AlphaFold | P01033 P49061 Q5RC60 Q95KL9 |
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks